Identification of urine biomarkers of endometriosis—Protein mass spectrometry
American Journal of Reproductive Immunology · 2024
DOI: 10.1111/aji.13856 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2024. Verfasst von Alenka Višnić und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Hospital Center Rijeka, Clinic for Gynecology and Obstetrics, Institute of Human Reproduction and Endocrinology, Rijeka, Croatia. Hauptthemen laut MEDLINE: Endometriosis, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben.
Abstract (Originalsprache)
Introduction
Endometriosis is a chronic inflammatory disease that leads to a series of pathological reactions. The basis is a changed proinflammatory activated immune system, which results in more pronounced oxidative stress, disturbed function of proteolysis and cell apoptosis. These processes are crucial in the development of the disease because their dysfunctional activities cause the progression of the disease. It is believed that the proteins excreted in the urine interact with each other and promote pathological processes in endometriosis.
Methods
We analyzed the urine proteome of patients and aimed to detect a potential protein biomarker for endometriosis in the urine proteome. We collected urine samples from 16 patients with endometriosis and 16 patients in the control group with functional ovarian cysts. The diagnosis for all patients was confirmed through pathohistological analysis. After the preanalytical preparation of the urine, chromatography and mass spectrometry (LC‐MS/MS) used the technology of urine proteome analysis.
Results
The main finding was a significantly different concentration of 14 proteins in the urine samples. We recorded a considerably higher concentration of proteins that have a significant role in activating the immune system (SELL), iron metabolism (HAMP) and cell apoptosis (CHGA) in endometriosis compared to controls. Proteins having an antioxidant function (SOD1) and a role in proteolysis of the extracellular matrix (MMP‐9) were significantly reduced in endometriosis compared to controls.
Conclusion
Consistent with the known pathogenesis of endometriosis, the study results complement the pathological responses that occur with disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Hospital Center Rijeka, Clinic for Gynecology and Obstetrics, Institute of Human Reproduction and Endocrinology, Rijeka, Croatia.
- Special Hospital Radiochirurgia Sveta Nedjelja, Zagreb, Croatia.
- Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
ORCID-Profile: Alenka Višnić, Dubravko Barišić, Gordana Čanadi Jurešić, Tina Sušanj Šepić, Neda Smiljan Severinski
Zitieren
APA
Višnić, A., Barišić, D., Čanadi Jurešić, G., Sušanj Šepić, T., & Smiljan Severinski, N. (2024). Identification of urine biomarkers of endometriosis—Protein mass spectrometry. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.13856
Vancouver
Višnić A, Barišić D, Čanadi Jurešić G, Sušanj Šepić T, Smiljan Severinski N. Identification of urine biomarkers of endometriosis—Protein mass spectrometry. American Journal of Reproductive Immunology. 2024. doi:10.1111/aji.13856
BibTeX
@article{Vini2024,
author = {Višnić, Alenka and Barišić, Dubravko and Čanadi Jurešić, Gordana and Sušanj Šepić, Tina and Smiljan Severinski, Neda},
title = {Identification of urine biomarkers of endometriosis—Protein mass spectrometry},
journal = {American Journal of Reproductive Immunology},
year = {2024},
doi = {10.1111/aji.13856}
}
EUVIMED